Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Respiratory Syncytial Virus Infections"
Show Display Options
Rank Status Study
1 Recruiting A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Conditions: Respiratory Syncytial Virus Infections;   Virus Diseases
Interventions: Drug: JNJ-53718678;   Drug: Placebo
2 Not yet recruiting Viral Inhibition in Children for Treatment of RSV
Condition: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Interventions: Drug: AK0529;   Drug: Placebo
3 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
4 Not yet recruiting Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID cp ΔM2-2 Vaccine;   Biological: Placebo
5 Not yet recruiting A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: MEDI8897;   Drug: Placebo
6 Not yet recruiting RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA-BN-RSV;   Other: Placebo
7 Not yet recruiting RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA-BN-RSV;   Other: Placebo
8 Recruiting Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID ΔM2-2 1030s vaccine;   Biological: Placebo
9 Recruiting A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers
Conditions: Respiratory Syncytial Virus Infections;   Influenza, Human
Interventions: Biological: RSV A Memphis 37;   Biological: Influenza A/California/04/2009
10 Not yet recruiting A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
11 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
12 Recruiting Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: D46cpΔM2-2 vaccine;   Biological: Placebo
13 Recruiting A Study of ALS-008176 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
14 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
15 Unknown  Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Conditions: Respiratory Distress Syndrome, Adult;   Respiratory Syncytial Virus Infections;   Pneumonia;   Acute Lung Injury
Intervention:
16 Recruiting Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: Presatovir;   Drug: Placebo
17 Recruiting Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study
Condition: Respiratory Syncytial Virus (RSV) Infection
Interventions: Drug: BTA-C585 oral capsule;   Drug: Matching placebo capsules
18 Recruiting TGF-(Beta) and Susceptibility to RSV
Conditions: Respiratory Syncytial Virus;   Asthma
Intervention:
19 Unknown  RSV Disease in the Elderly
Conditions: Respiratory Infections, Acute;   Respiratory Syncytial Virus
Intervention:

Indicates status has not been verified in more than two years